Clinical trials
Phase 2 Spondylitis, Ankylosing trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 6 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Unknown status | 7 |
| Terminated | 5 |
| Recruiting | 3 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Charite University, Berlin, Germany | 5 |
| AbbVie | 2 |
| Lakefront Biotherapeutics NV | 2 |
| Novartis Pharmaceuticals | 2 |
| Pfizer | 2 |
| Sanofi | 2 |
| UCB Biopharma SRL | 2 |
| Advanced Accelerator Applications | 1 |
| Akeso | 1 |
| Amgen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Spondylitis, Ankylosing | 43 |
| Arthritis, Psoriatic | 6 |
| Arthritis, Rheumatoid | 6 |
| Arthritis | 4 |
| Axial Spondyloarthritis | 4 |
| Spondylarthritis | 4 |
| Crohn Disease | 3 |
| Spondylitis | 3 |
| Colitis, Ulcerative | 2 |
| Granulomatosis with Polyangiitis | 2 |
Trials
Showing 51 to 43 of 43. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.